Jarushka Naidoo

Prof. Jarushka Naidoo is Professor of Medical Oncology at RCSI University of Medicine and Health Sciences and a Consultant Medical Oncologist at the Beaumont RCSI Cancer Centre in Dublin, Ireland. A globally recognised authority on immune-related adverse events from checkpoint inhibitors in non-small cell lung cancer, she has authored over 100 publications, contributed to ASCO guidelines on the management of immunotherapy toxicity, and leads the Beaumont RCSI Irish Cancer Society Lung Outreach Programme. She serves as National Lung Cancer Lead for Cancer Trials Ireland, holds an adjunct assistant professorship at Johns Hopkins University, and is a frequent speaker at major international congresses.